RIGEL director granted 5,750 RSUs

RIGEL PHARMACEUTICALS INC director Alison L. Hannah received an equity award in the form of Restricted Stock Units.

Rhea-AI Filing Summary

RIGEL PHARMACEUTICALS INC director Alison L. Hannah received an equity award in the form of Restricted Stock Units. The filing shows a grant of 5,750 shares of Common Stock at a price of $0.00 per share, reflecting a compensation-related award rather than a market purchase.

These shares are to be acquired upon vesting of the Restricted Stock Unit award. According to the terms, the units will fully vest on the date prior to the company’s next Annual Meeting, as long as she continues to serve on the Board of Directors. After this grant, her direct Common Stock holdings reported in this filing total 16,375 shares.

Insider Trade Summary

Grant/Award: 5,750 shares

Grant/Award 1 txn

Insider HANNAH ALISON L.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,750	$0.00	$0.00

Holdings After Transaction: Common Stock — 16,375 shares (Direct)

Footnotes (1)

1. F1. The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Key Figures

RSU shares granted: 5,750 shares Grant price per share: $0.00 per share Total shares after transaction: 16,375 shares +1 more

4 metrics

RSU shares granted 5,750 shares Restricted Stock Unit award to director on May 15, 2026

Grant price per share $0.00 per share Indicates non-cash equity compensation award

Total shares after transaction 16,375 shares Director’s direct Common Stock holdings after grant

Vesting condition Fully vests before next Annual Meeting Subject to continuous Board service

Key Terms

Restricted Stock Unit, Annual Meeting, continuous service, Board of Directors

4 terms

Restricted Stock Unit financial

"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Annual Meeting financial

"The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

continuous service other

"subject to the Reporting Person's continuous service on the Company's Board of Directors."

Board of Directors financial

"subject to the Reporting Person's continuous service on the Company's Board of Directors."

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did RIGEL (RIGL) disclose for Alison L. Hannah?

RIGEL reported that director Alison L. Hannah received a grant of 5,750 Restricted Stock Units. These units represent shares of Common Stock awarded as compensation, not purchased on the open market, and increase her reported direct holdings to 16,375 shares after the transaction.

How many RIGEL (RIGL) shares were granted in this Form 4 filing?

The Form 4 shows a grant of 5,750 shares of Common Stock through Restricted Stock Units. The transaction price is listed as $0.00 per share, indicating a compensation award rather than a cash purchase, typical for director equity incentives at public companies.

When do Alison L. Hannah’s RIGEL Restricted Stock Units vest?

The Restricted Stock Units will fully vest on the date prior to RIGEL’s next Annual Meeting. Vesting is conditioned on Alison L. Hannah’s continuous service on the company’s Board of Directors through that date, aligning the award with ongoing board service requirements.

What are Alison L. Hannah’s total RIGEL (RIGL) share holdings after this transaction?

Following the grant reported in the Form 4, Alison L. Hannah’s direct holdings of RIGEL Common Stock total 16,375 shares. This figure includes the newly awarded shares associated with the Restricted Stock Unit grant disclosed in the insider filing.

Is the RIGEL (RIGL) Form 4 transaction a market buy or a grant?

The Form 4 describes a grant or award acquisition, not a market buy. Alison L. Hannah received 5,750 shares at $0.00 per share through a Restricted Stock Unit award, a standard form of non-cash director compensation tied to future vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 08:49 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HANNAH ALISON L.

(Last) (First) (Middle)

RIGEL PHARMACEUTICALS, INC.

611 GATEWAY BLVD, SUITE 900

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RIGEL PHARMACEUTICALS INC [ RIGL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		A		5,750(1)	A	$0	16,375	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.

	/s/ Raymond Furey (Attorney-in-Fact)	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)